However, Rh2, by enhancing ROS, partially counteracts p53-induced apoptosis by activating AMPK and NF-κB signaling pathways to promote cancer survival and growth and can exert better anticancer effects when applied in combination with antioxidants (Li et al., 2011). This evidence concerns the gene RHAG and cancer.